Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort. Issue 6 (24th March 2021)

• Record Type: Journal Article
• Authors: Papadopoulos, Nikolaos G.; Mathioudakis, Alexander G.; Custovic, Adnan; Deschildre, Antoine; Phipatanakul, Wanda; Wong, Gary; Xepapadaki, Paraskevi; Abou‐Taam, Rola; Agache, Ioana; Castro‐Rodriguez, Jose A.; Chen, Zhimin; Cros, Pierrick; Dubus, Jean‐Christophe; El‐Sayed, Zeinab Awad; El‐Owaidy, Rasha; Feleszko, Wojciech; Fierro, Vincenzo; Fiocchi, Alessandro; Garcia‐Marcos, Luis; Goh, Anne; Hossny, Elham M.; Huerta Villalobos, Yunuen R.; Jartti, Tuomas; Le Roux, Pascal; Levina, Julia; López García, Aida Inés; Ramos, Ángel Mazón; Morais‐Almeida, Mário; Murray, Clare; Nagaraju, Karthik; Nagaraju, Major K.; Navarrete Rodriguez, Elsy Maureen; Namazova‐Baranova, Leyla; Nieto Garcia, Antonio; Pozo Beltrán, Cesar Fireth; Ratchataswan, Thanaporn; Rivero Yeverino, Daniela; Rodríguez Zagal, Eréndira; Schweitzer, Cyril E.; Tulkki, Marleena; Wasilczuk, Katarzyna; Xu, Dan;
• Other Names: Alekseeva Anna investigator.; Almeida Bethan investigator.; Andre Maud investigator.; Arimova Polina investigator.; Blonde Aurore investigator.; Cunningham Amparito investigator.; Da Mota Sofia investigator.; Efendieva Kamilla investigator.; Kalugina Vera investigator.; Kiefer Sébastien investigator.; Klein Anais investigator.; López Chrystopherson Gengyny Caballero investigator.; López Juan Jesús Ríos investigator.; Moratellti Caroline investigator.; Fuentes Pérez Miguel investigator.; Simermann Meryl investigator.; Tapia José Sergio Papaqui investigator.; Tatopoulos Aurelie investigator.; Vishneva Elena investigator.; Volkov Κonstantin investigator.; Bacharier Leonard investigator.; Bonini Matteo investigator.; Craig Timothy investigator.; Diamant Zuzana investigator.; Ducharme Francine M investigator.; Gern James E. investigator.; Grigg Jonathan investigator.; Hamelmann Eckard H investigator.; Hedlin Gunilla investigator.; Jartti Tuomas investigator.; Kalayci Omer investigator.; Kaplan Alan investigator.; Konradsen Jon investigator.; Kuna Piotr investigator.; Lau Susanne investigator.; Le Souef Peter investigator.; Lemanske Robert F investigator.; Makela Mika J investigator.; Matricardi Paolo M investigator.; Gómez René‐Maximiliano investigator.; Miligkos Michael investigator.; Pitrez Paulo MC investigator.; Price David investigator.; Pohunek Petr investigator.; Roberts Graham C investigator.; Sheikh Aziz investigator.; Tsiligianni Ioanna investigator.; Turner Steve investigator.; Valiulis Arunas investigator.; Winders Tonya investigator.; Yusuf Osman M investigator.; Zar Heather investigator.;
• Is Part Of: Allergy. Volume 76:Issue 6(2021)
• Page Start: 1765
• Page End: 1775
• Publication Date: 2021-03-24
• Subjects: childhood asthma -- coronavirus -- COVID‐19; Allergy -- Periodicals; 616.97
• DOI: 10.1111/all.14787
• Languages: English
• ISSNs: 0105-4538

Abstract

Abstract: Background: The interplay between COVID‐19 pandemic and asthma in children is still unclear. We evaluated the impact of COVID‐19 pandemic on childhood asthma outcomes. Methods: The PeARL multinational cohort included 1, 054 children with asthma and 505 non‐asthmatic children aged between 4 and 18 years from 25 pediatric departments, from 15 countries globally. We compared the frequency of acute respiratory and febrile presentations during the first wave of the COVID‐19 pandemic between groups and with data available from the previous year. In children with asthma, we also compared current and historical disease control. Results: During the pandemic, children with asthma experienced fewer upper respiratory tract infections, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks, and hospitalizations due to asthma, in comparison with the preceding year. Sixty‐six percent of asthmatic children had improved asthma control while in 33% the improvement exceeded the minimal clinically important difference. Pre‐bronchodilatation FEV1 and peak expiratory flow rate were improved during the pandemic. When compared to non‐asthmatic controls, children with asthma were not at increased risk of LRTIs, episodes of pyrexia, emergency visits, or hospitalizations during the pandemic. However, an increased risk of URTIs emerged. Conclusion: Childhood asthma outcomes, including control, were improved during the first wave of the COVID‐19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID‐19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent. Abstract : This study evaluates the frequency of acute respiratory and febrile presentations furing the first wave of COVID‐19 pandemic in childhood asthma. Data from the multinational PeARL cohort reveal improved health and asthma activity during the first wave of the COVID‐19 pandemic, probably attributed to decreased exposure to asthma triggers and increased treatment adherence. During that period, children with asthma experienced fewer URTIs, episodes of pyrexia, emergency visits, hospital admissions, asthma attacks and hospitalizations due to asthma, in comparison to the preceding year. Abbreviations: COVID‐19, coronavirus disease 2019; LRTI, lower respiratory tract infections; FEV1, forced expiratory value in 1 second; PeARL, Pediatric Asthma in Real Life; PFR, peak respiratory flow rate; URTI, upper respiratory tract infections.